GlassScriptPhysician profile
Catherine Brooke Cotney
NPI 1356662894
$894.97
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $144 · 2021: $115 · 2022: $151 · 2023: $154 · 2024: $56.60 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $173.03 | 2019-2022 | |
| Sobi, INC | $137.83 | 2019-2023 | |
| Sanofi Pasteur INC. | $97.80 | 2021-2023 | |
| Glaxosmithkline, LLC. | $88.94 | 2019-2023 | Bexsero |
| Corium, LLC | $86.72 | 2025 | Azstarys |
| Merck Sharp & Dohme LLC | $82.72 | 2019-2024 | Vaxelis, Gardasil 9, Proquad |
| Sanofi-Aventis U.S. LLC | $69.67 | 2024-2025 | |
| Genentech USA, INC. | $33.83 | 2020 | |
| Verrica Pharmaceuticals INC. | $33.26 | 2024-2025 | Ycanth |
| Pfizer INC. | $31.05 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $18.39 | 2019 | |
| Seqirus USA INC | $14.41 | 2025 | Flucelvax |
| Alk-Abello, INC | $13.94 | 2023 | Odactra, Ragwitek, Grastek |
| Adlon Therapeutics L.P. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Cotney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.